
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Rev Esp Cardiol (Engl Ed), 75 (5), 429
DOI 10.1016/j.rec.2022.04.003, PubMed 35525570
Integrin α11β1 and syndecan-4 dual receptor ablation attenuates cardiac hypertrophy in the pressure overloaded heart
Am J Physiol Heart Circ Physiol (in press)
DOI 10.1152/ajpheart.00635.2021, PubMed 35522553
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol (in press)
DOI 10.33963/KP.a2022.0117, PubMed 35521719
More publications